Operator Good day and welcome to the alboreto pharma first quarter 2021 earnings conference call. [Operator Instructions] At this time, I would like to turn the conference over to Mr. Paul. Please go ahead, sir. Paul S. Bavier -- Interim President, General Counsel And Secretary Thank you, operator and good morning everyone. Thank you for joining today's call. This morning, Alberto issued a press release highlighting its recent business accomplishments and reporting its financial results for the first quarter ended March 31 2021. This press release is accessible via the company's website at www dot albireo pharma.com. Before proceeding, we would like to note that management's comments today may include bold looking statements regarding the company's plans and expectations. These statements are being made under the private securities litigation Reform Act of 1995. And they are subject to various risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the risk factors section of the company's most recent form 10k and the subsequent SEC filings. These filings can be accessed from the media and investors section of the company's website at www dot albireo pharma.com or on the SEC is website. Any forward looking statements represent management's views as of today, Thursday, May 6 2021, and should not be relied upon as representing their views as of any subsequent dates. The company undertakes no obligation to update these statements publicly.